Vertigo News and Research

Latest Vertigo News and Research

Sighted people can be trained to use echolocation to estimate sizes of enclosed spaces

Humans can be trained to use echolocation to estimate the sizes of enclosed spaces. Ludwig-Maximilians-Universitaet in Munich researchers now show that the learning process involves close coordination between sensory and motor cortex.

28 Jan 2017

Vestibular thresholds begin to increase above age 40, new study finds

A new study led by researchers at Massachusetts Eye and Ear found that vestibular thresholds begin to double every 10 years above the age of 40, representing a decline in our ability to receive sensory information about motion, balance and spatial orientation.

28 Nov 2016

Novartis gets three FDA approvals for expanded use of biologic drug to treat rare autoinflammatory diseases

Novartis announced today that the US Food and Drug Administration has granted three simultaneous approvals for the expanded use of Ilaris (canakinumab) to treat three rare and distinct types of Periodic Fever Syndromes.

24 Sep 2016

Noise levels in nightclubs may induce hearing loss

A new study raises concerns about the noise level in nightclubs. Researchers in Southern California have found that the average continuous level of noise in some nightclubs is at least 91.2 dBA (A-weighted decibels).

16 Sep 2016

UTSW surgeons remove acoustic neuromas through small incisions in the ear canals

A surgical team at UT Southwestern Medical Center is helping to pioneer a new minimally invasive procedure that extracts vertigo-inducing tumors from the inner ear without having to remove a large piece of skull, as is usually required.

15 Sep 2016

$Study finds older adults who sustain wrist fractures more likely to have poor balance$

Study finds older adults who sustain wrist fractures more likely to have poor balance

Elderly patients suffering a low energy wrist (distal radius) fracture are more likely to have difficulties with balance, placing them at risk for future injuries, according to a new study appearing in the July 20, 2016 issue of the Journal of Bone and Joint Surgery.

21 Jul 2016

Nearly 3.3 million children in U.S. have dizziness or balance problem

More than 1 in 20 (nearly 3.3 million) children between the ages of 3 and 17 have a dizziness or balance problem, according to an analysis of the first large-scale, nationally representative survey of these problems in U.S. children.

28 Jan 2016

Results from STRIVE trial of enzalutamide versus bicalutamide in CRPC published in Journal of Clinical Oncology

Astellas US LLC, a United States (U.S.) subsidiary of Tokyo-based Astellas Pharma Inc., and Medivation, Inc. today announced that results from the STRIVE trial of enzalutamide compared to bicalutamide in men with castration-resistant prostate cancer (CRPC) were published in the Journal of Clinical Oncology.

27 Jan 2016

FDA permits Sound Pharmaceuticals to start SPI-1005 clinical trial for treatment of Meniere's Disease

Sound Pharmaceuticals is pleased to announce that it began enrolling a clinical trial to test SPI-1005 in the treatment of Meniere's Disease (MD). MD or idiopathic endolymphatic hydrops is an inner ear disease that involves episodic vertigo, sensorineural hearing loss, and tinnitus.

5 Jan 2016

Hospira announces TGA approval of Inflectra (infliximab) for treatment of eight inflammatory conditions

Hospira today announced that Inflectra (infliximab), the first monoclonal antibody (mAb) biosimilar therapy, has been registered in Australia. This registration paves the way for the Federal Government to reduce the cost of some of the most expensive medicines on the Pharmaceutical Benefits Scheme (PBS).

20 Aug 2015

Enzalutamide Phase 2 study for AR positive triple-negative breast cancer meets primary endpoint

Astellas Pharma Inc. announced that data from a Phase 2 study evaluating the investigational use of enzalutamide as a single agent for the treatment of advanced androgen receptor (AR) positive, triple-negative breast cancer (TNBC) were presented during an oral abstracts session at the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.

2 Jun 2015

Aptensio XR once-daily treatment for ADHD to be available in Summer 2015

Today, Rhodes Pharmaceuticals L.P. announced that Aptensio XR, a once-daily central nervous system stimulant indicated for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) will be available to patients beginning Summer 2015.

22 May 2015

National survey shows that most women don't know risks or symptoms of stroke

A national survey released today by The Ohio State University Wexner Medical Center shows that most women don't know the risks or symptoms females face when it comes to having a stroke.

28 Apr 2015

Astellas Pharma, Medivation announce topline results from enzalutamide Phase 2 STRIVE trial

Astellas Pharma Inc. and Medivation, Inc. today announced topline results from the Phase 2 STRIVE trial comparing enzalutamide with bicalutamide in a study population of men with non-metastatic or metastatic castration-resistant prostate cancer.

2 Apr 2015

23andMe announces publication of genome-wide association study of motion sickness

23andMe, Inc., the leading personal genetics company, today announced the publication of the first ever genome-wide association study of motion sickness.

4 Feb 2015

Whole exome sequencing helps Mayo Clinic neurologist solve a medical mystery

Precision medicine is getting a jump-start from a new national initiative announced in President Obama's State of the Union message. One Georgia family has already experienced its benefits: genomic testing called whole exome sequencing helped Mayo Clinic neurologist Zbigniew Wszolek, M.D., solve a medical mystery that had left a boy with painful, jerking spasms that at times prevented him from walking or talking.

4 Feb 2015

Mylan gets tentative approval from FDA for two pediatric dosages of abacavir/lamivudine tablets

Mylan Inc. today announced that its subsidiary Mylan Laboratories Limited has received tentative approval from the U.S. Food and Drug Administration for its New Drug Applications (NDAs) for two dosages of abacavir/lamivudine tablets for oral suspension for the treatment of HIV-1 infection in pediatric patients.

4 Dec 2014

FDA accepts Eisai's sNDA for perampanel drug for treatment of PGTC seizures

Eisai Inc. announced today that the U.S. Food and Drug Administration (FDA) accepted for review the company's Supplemental New Drug Application (sNDA) for its in-house-discovered AMPA receptor antagonist perampanel for the treatment of primary generalized tonic-clonic (PGTC) seizures.

20 Oct 2014

Now, women experiencing morning sickness can benefit from Diclegis drug

Up to 85 percent of pregnant women are affected by nausea and vomiting of pregnancy (NVP), more commonly known as morning sickness.

10 Sep 2014

Treatments that involve neck manipulation may be linked with strokes

Treatments that involve neck manipulation may be associated with strokes, although this association is not proven, according to an American Heart Association Scientific Statement written by lead author Dr. Jose Biller of Loyola University Medical Center and other stroke experts.

13 Aug 2014

Vertigo News and Research

Latest Vertigo News and Research

Sighted people can be trained to use echolocation to estimate sizes of enclosed spaces

Vestibular thresholds begin to increase above age 40, new study finds

Novartis gets three FDA approvals for expanded use of biologic drug to treat rare autoinflammatory diseases

Noise levels in nightclubs may induce hearing loss

UTSW surgeons remove acoustic neuromas through small incisions in the ear canals

Study finds older adults who sustain wrist fractures more likely to have poor balance

Nearly 3.3 million children in U.S. have dizziness or balance problem

Results from STRIVE trial of enzalutamide versus bicalutamide in CRPC published in Journal of Clinical Oncology

FDA permits Sound Pharmaceuticals to start SPI-1005 clinical trial for treatment of Meniere's Disease

Hospira announces TGA approval of Inflectra (infliximab) for treatment of eight inflammatory conditions

Enzalutamide Phase 2 study for AR positive triple-negative breast cancer meets primary endpoint

Aptensio XR once-daily treatment for ADHD to be available in Summer 2015

National survey shows that most women don't know risks or symptoms of stroke

Astellas Pharma, Medivation announce topline results from enzalutamide Phase 2 STRIVE trial

23andMe announces publication of genome-wide association study of motion sickness

Whole exome sequencing helps Mayo Clinic neurologist solve a medical mystery

Mylan gets tentative approval from FDA for two pediatric dosages of abacavir/lamivudine tablets

FDA accepts Eisai's sNDA for perampanel drug for treatment of PGTC seizures

Now, women experiencing morning sickness can benefit from Diclegis drug

Treatments that involve neck manipulation may be linked with strokes

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Vertigo News and Research

Latest Vertigo News and Research

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Newsletters you may be interested in